open access

Vol 27, No 1 (2020)
Original articles — Clinical cardiology
Published online: 2018-08-14
Get Citation

Implantation of the Micra transcatheter pacing system: Single Polish center experience with the real costs of hospitalization analysis

Marcin Grabowski, Marcin Michalak, Monika Gawałko, Sylwia Gajda, Andrzej Cacko, Łukasz Januszkiewicz, Agnieszka Kołodzińska, Przmysław P. Mitkowski, Gabor Z. Duray, Grzegorz Opolski
DOI: 10.5603/CJ.a2018.0075
·
Pubmed: 30155871
·
Cardiol J 2020;27(1):47-53.

open access

Vol 27, No 1 (2020)
Original articles — Clinical cardiology
Published online: 2018-08-14

Abstract

Background: The Micra transcatheter pacing system (TPS) is a miniaturized, single-chamber pacemaker system. Study reported herein is an initial experience with implantation of the Micra TPS.

Methods: The leadless pacemaker was implanted in 10 patients with standard indications for a permanent pacemaker implantation. All hospitalization costs were calculated for all patients.

Results: The mean age of the patients was 75 ± 7.1 years, 6 were men and 4 were women. Four patients had permanent atrial fibrillation as the basal rhythm and 6 patients had sinus rhythm. All patients had at least one relative contraindication that precluded the use of a traditional pacing system. Mean intraoperative ventricular sensing amplitude was 10.6 ± 5.4 mV, impedance 843 ± 185 ohms, and pacing threshold at 0.24 ms was 0.56 ± 0.23 V. At discharge, those values were 13.9 ± 5.6 mV, 667 ± 119 ohms and 0.47 ± 0.17, respectively. The mean duration of implantation procedure was 82 min, while mean fluoroscopy time was 3.5 min. Two patients developed hematoma at the groin puncture site post-implantation. In 1 case there was a need for erythrocyte mass transfusion and surgical intervention. Mean total time of hospitalization was 26 days and time from procedure to discharge 12 days. Average cost of hospitalization per 1 patient was 11,260.15 EUR minimal cost was 9,052.68 EUR, while maximal cost was 16,533.18 EUR.

Conclusions: Implantation of leadless pacemakers is feasible, safe and provides advantages over the conventional system. Hospitalization costs vary for individual patients in wide range.

Abstract

Background: The Micra transcatheter pacing system (TPS) is a miniaturized, single-chamber pacemaker system. Study reported herein is an initial experience with implantation of the Micra TPS.

Methods: The leadless pacemaker was implanted in 10 patients with standard indications for a permanent pacemaker implantation. All hospitalization costs were calculated for all patients.

Results: The mean age of the patients was 75 ± 7.1 years, 6 were men and 4 were women. Four patients had permanent atrial fibrillation as the basal rhythm and 6 patients had sinus rhythm. All patients had at least one relative contraindication that precluded the use of a traditional pacing system. Mean intraoperative ventricular sensing amplitude was 10.6 ± 5.4 mV, impedance 843 ± 185 ohms, and pacing threshold at 0.24 ms was 0.56 ± 0.23 V. At discharge, those values were 13.9 ± 5.6 mV, 667 ± 119 ohms and 0.47 ± 0.17, respectively. The mean duration of implantation procedure was 82 min, while mean fluoroscopy time was 3.5 min. Two patients developed hematoma at the groin puncture site post-implantation. In 1 case there was a need for erythrocyte mass transfusion and surgical intervention. Mean total time of hospitalization was 26 days and time from procedure to discharge 12 days. Average cost of hospitalization per 1 patient was 11,260.15 EUR minimal cost was 9,052.68 EUR, while maximal cost was 16,533.18 EUR.

Conclusions: Implantation of leadless pacemakers is feasible, safe and provides advantages over the conventional system. Hospitalization costs vary for individual patients in wide range.

Get Citation

Keywords

leadless pacemakers, complications, procedure cost, hospitalization cost

About this article
Title

Implantation of the Micra transcatheter pacing system: Single Polish center experience with the real costs of hospitalization analysis

Journal

Cardiology Journal

Issue

Vol 27, No 1 (2020)

Pages

47-53

Published online

2018-08-14

DOI

10.5603/CJ.a2018.0075

Pubmed

30155871

Bibliographic record

Cardiol J 2020;27(1):47-53.

Keywords

leadless pacemakers
complications
procedure cost
hospitalization cost

Authors

Marcin Grabowski
Marcin Michalak
Monika Gawałko
Sylwia Gajda
Andrzej Cacko
Łukasz Januszkiewicz
Agnieszka Kołodzińska
Przmysław P. Mitkowski
Gabor Z. Duray
Grzegorz Opolski

References (12)
  1. Udo EO, Zuithoff NPA, van Hemel NM, et al. Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm. 2012; 9(5): 728–735.
  2. Kirkfeldt RE, Johansen JB, Nohr EA, et al. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014; 35(18): 1186–1194.
  3. Ritter P, Duray GZ, Steinwender C, et al. Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study. Eur Heart J. 2015; 36(37): 2510–2519.
  4. Knops RE, Tjong FVY, Neuzil P, et al. Chronic performance of a leadless cardiac pacemaker: 1-year follow-up of the LEADLESS trial. J Am Coll Cardiol. 2015; 65(15): 1497–1504.
  5. El-Chami MF, Roberts PR, Kypta A, et al. How to Implant a Leadless Pacemaker With a Tine-Based Fixation. J Cardiovasc Electrophysiol. 2016; 27(12): 1495–1501.
  6. Sohail MR, Hussain S, Le KY, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007; 49(18): 1851–1859.
  7. Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010; 121(3): 458–477.
  8. Kypta A, Blessberger H, Kammler J, et al. Leadless cardiac pacemaker implantation after lead extraction in patients with severe device infection. J Cardiovasc Electrophysiol. 2016; 27(9): 1067–1071.
  9. Reynolds D, Duray G, Omar R, et al. A Leadless Intracardiac Transcatheter Pacing System. N Engl J Med. 2016; 374(6): 533–541.
  10. Roberts PR, Clementy N, Al Samadi F, et al. A leadless pacemaker in the real-world setting: The Micra Transcatheter Pacing System Post-Approval Registry. Heart Rhythm. 2017; 14(9): 1375–1379.
  11. Reddy VY, Exner DV, Cantillon DJ, et al. Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker. N Engl J Med. 2015; 373(12): 1125–1135.
  12. Duray GZ, Ritter P, El-Chami M, et al. Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study. Heart Rhythm. 2017; 14(5): 702–709.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl